
ClearPoint Neuro CLPT
$ 10.38
3.7%
Annual report 2025
added 03-17-2026
ClearPoint Neuro Interest Expense 2011-2026 | CLPT
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense ClearPoint Neuro
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -146 K | -40 K | -29 K | -22 K | 973 K | 1.44 M | 955 K | 980 K | 873 K | 1.05 M | 1.26 M | 1.02 M | 500 K | 2.59 M | 2.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.59 M | -146 K | 928 K |
Quarterly Interest Expense ClearPoint Neuro
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -64 K | -52 K | 4 K | - | -11 K | 5 K | -26 K | - | -12 K | -2 K | -11 K | - | -25 K | -8 K | 11 K | - | 62 K | 240 K | 332 K | - | 201 K | 197 K | 842 K | - | 213 K | 259 K | 254 K | - | 247 K | 248 K | 247 K | - | 211 K | 213 K | 213 K | - | 240 K | 251 K | 345 K | - | 317 K | 312 K | 308 K | - | 289 K | 284 K | 151 K | - | 128 K | 130 K | 106 K | - | 85.8 K | 96 K | 2.33 M | - | 706 K | 598 K | 542 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.33 M | -64 K | 244 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
7.68 M | $ 184.69 | 2.23 % | $ 13.8 B | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
AxoGen
AXGN
|
167 K | $ 34.46 | 2.96 % | $ 1.59 B | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 12.77 | 3.65 % | $ 1.73 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 292.23 | 1.41 % | $ 8.24 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.37 | 1.35 % | $ 126 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 39.9 | 2.18 % | $ 5.94 K | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 63.82 | 1.01 % | $ 94.5 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Inogen
INGN
|
2.44 M | $ 6.34 | -1.71 % | $ 169 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
78 K | $ 25.21 | 1.47 % | $ 213 M | ||
|
LENSAR
LNSR
|
636 K | $ 6.04 | 2.03 % | $ 72.2 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 94.94 | 2.11 % | $ 12.8 B | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.98 | -2.46 % | $ 1.2 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.44 | 3.74 % | $ 940 M | ||
|
Myomo
MYO
|
-668 K | $ 0.79 | 8.49 % | $ 33.1 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 17.86 | 5.37 % | $ 419 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 10.88 | 4.11 % | $ 390 M | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 56.83 | 3.48 % | $ 1.67 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 39.73 | 3.3 % | $ 1.23 B | ||
|
LivaNova PLC
LIVN
|
664 K | $ 64.99 | 0.63 % | $ 3.55 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 88.63 | 1.03 % | $ 3.08 B | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.76 | 0.27 % | $ 123 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 78.2 | 0.1 % | $ 45.7 B |